- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Ommaya Reservoir.
Displaying page 1 of 1.
EudraCT Number: 2018-002813-37 | Sponsor Protocol Number: AB-CSF-001 | Start Date*: 2018-09-27 |
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna | ||
Full Title: Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors – a pilot study | ||
Medical condition: Malignant childhood central nervous system tumors | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006234-39 | Sponsor Protocol Number: GB5121-2101 | Start Date*: 2022-12-09 | ||||||||||||||||
Sponsor Name:GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | ||||||||||||||||||
Full Title: A Phase 1b/2, open-label dose escalation with expansion study of GB5121 in adult patients with relapsed/refractory primary or secondary central nervous system lymphoma or primary vitreoretinal lymp... | ||||||||||||||||||
Medical condition: Relapsed/refractory primary or secondary central nervous system lymphoma or primary vitreoretinal lymphoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Prematurely Ended) NL (Prematurely Ended) SE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002618-40 | Sponsor Protocol Number: HIT-REZ-2005 | Start Date*: 2005-12-13 | |||||||||||
Sponsor Name:Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital | |||||||||||||
Full Title: HIT-REZ 2005 - A multicentre clinical trial and phase II study for the treatment of refractory and relapsed primitive neuroectodermal tumours (medulloblastomas, supratentorial PNETs) and ependymoma... | |||||||||||||
Medical condition: P-HIT-REZ 2005 study: Refractory and relapsed primitive neuroectodermal brain tumours (medulloblastomas, supratentorial PNETs) E-HIT-REZ 2005 study (Phase II Study "Oral therapy with temozolomide... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001739-29 | Sponsor Protocol Number: MedOPP243 | Start Date*: 2020-05-25 | ||||||||||||||||
Sponsor Name:Medica Scientia Innovation Research S.L. (MEDSIR) | ||||||||||||||||||
Full Title: A Multicenter, Open-Label, Single-Arm, Multicohort Phase II Clinical Trial of Trastuzumab Deruxtecan (DS-8201a) in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer wi... | ||||||||||||||||||
Medical condition: Pretreated, unresectable locally advanced or metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-positive or HER2-low expressing breast cancer (BC) with untreated or treated brain metastases... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) PT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.